CD163 and Alzheimer disease: In AD skin, with immense monocyte extravasation, amounts of laminin-α2 available to CD68+ MOMF reduced, (Figs. 1D, 4C) suggesting the CD163-driving capacity required to safeguard S1 identity became limited.